GLAXOSMITHKLINE, LLC: $81.3M Department of Health and Human Services Contract Vehicle
Summary
The CDC awarded $81.3M to GlaxoSmithKline, LLC for pediatric flu vaccines. Since the recipient is a private entity, no publicly traded companies directly benefit from this contract.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.The recipient is private, so no public company is directly impacted.
- 2.The contract supports pediatric flu vaccine supply but is not a market-moving event.
- 3.Investors should not infer benefits to competitors or supply chain partners without concrete evidence.
Market Implications
Given that GlaxoSmithKline, LLC is private, there are no direct market implications for publicly traded companies. The broader vaccine sector may see indirect sentiment from continued government spending on flu prevention, but no specific company can be tied to this award. Retail investors should not adjust positions based on this contract.
Full Analysis
The Department of Health and Human Services, through the Centers for Disease Control and Prevention, awarded an indefinite delivery/indefinite quantity contract worth $81.3M to GlaxoSmithKline, LLC for pediatric flu vaccines. The contract runs from December 2025 through February 2027. GlaxoSmithKline, LLC is a private entity and not a publicly traded company or recognized subsidiary, so this contract does not directly flow to any public company. While vaccine spending generally supports the broader healthcare sector, no specific public ticker can be attributed without introducing false positives. The contract is a routine public health procurement and does not signal a shift in sector dynamics. No related legislation directly connects to this award, as the relevant bill signals in the database lack specific funding or policy mechanisms for pediatric flu vaccines.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
GLAXOSMITHKLINE, LLC: $678M Department of Health and Human Services Contract Vehicle
GLAXOSMITHKLINE, LLC: $653M Department of Health and Human Services Contract Vehicle
GLAXOSMITHKLINE, LLC: $793M Department of Health and Human Services Contract Vehicle
GLAXOSMITHKLINE, LLC: $10.4M Department of Health and Human Services Contract Vehicle
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Restoring Reciprocity in Government Procurement
This Presidential Memorandum directs the Office of Management and Budget, the U.S. Trade Representative, and other federal agencies to identify and remove Canadian-origin items from federal civil procurement where possible, citing Canada's 'Buy Canadian' policies as discriminatory. It also requires agencies to be notified of domestic alternatives and mandates ongoing monitoring of Canada's procurement practices, with provisions for restoring access if Canada changes its policies.
Excluding Certain Canadian Alcoholic Beverages from Importation into the United States in Response to Continued Discrimination Against the Commerce of the United States with Respect to Alcoholic Beverages
President Trump, invoking Section 338 of the Tariff Act of 1930, orders an import ban on certain Canadian alcoholic beverages effective September 29, 2026, escalating previous 50% ad valorem duties. This action targets Canadian discrimination against U.S. alcoholic beverages, citing Canada's broken commitments and additional retaliation. The ban replaces the tariff for specified products with a complete exclusion from entry into the United States.
Contract Details
Recipient
GLAXOSMITHKLINE, LLC
Award Amount
$81,300,001
Awarding Agency
Department of Health and Human Services
Sub-Agency
Centers for Disease Control and Prevention
Contract Type
INDEFINITE DELIVERY / INDEFINITE QUANTITY
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →